Tag: Comaneci
Rapid Medical announces enrolment of final patient in post-market SUCCESS study
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the...
Rapid Medical announces new data showing “significant advantages” of Comaneci for...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...
Rapid Medical receives FDA Breakthrough Device designation for vasospasm treatment
Rapid Medical has announced US Food and Drug Administration (FDA) Breakthrough Device designation for its Comaneci embolisation assist technology, which is intended to facilitate the treatment of...
Rapid Medical device proves promising for safely supporting aneurysm coiling occlusion
The Comaneci device from Rapid Medical offers a promising and reliable way of safely supporting aneurysm coiling occlusion, even in a rupture environment. That is...
Rapid Medical announces $9M in new funding
Rapid Medical has completed a Series B financing of $9M to advance the commercialisation of the company’s minimally invasive stroke treatment and prevention products, the Tigertriever...
Rapid Medical reaches 500 successful aneurysm treatments with Comaneci
Rapid Medical has announced that its Comaneci adjustable remodelling mesh has exceeded 500 successfully treated aneurysms worldwide. This milestone comes two years after the...
First clinical report on Comaneci device shows good aneurysm occlusion
In the Journal of NeuroInterventional Surgery (JNIS), Tufail Patankar (Department of Neuroradiology, Leeds Teaching Hospital, Leeds, UK) and colleagues present the first clinical report...
